In vitro activity of trovafloxacin against Chlamydia pneumoniae
- PMID: 9303410
- PMCID: PMC164061
- DOI: 10.1128/AAC.41.9.2033
In vitro activity of trovafloxacin against Chlamydia pneumoniae
Abstract
The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and a minimal concentration at which 90% of the isolates are killed of 1.0 microg/ml, but trovafloxacin was less active than doxycycline, erythromycin, and azithromycin.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
